Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Providers increasingly field questions about BPC-157, making it important to understand the current evidence, the types on the market, and the regulatory landscape
10.1186/s13045-024-01564-3 5 ChenF.ZhangY.ChandrashekarD
62929125-001) Last Reviewed: 28 April 2026 Want to have beautiful, glowing skin
FDA staff's own briefing document, posted publicly ahead of the meeting as part of the docket, proposes that TB-500 (free base) and TB-500 acetate not be added to the list, citing incomplete physicochemical characterization, a lack of evidence of effectiveness for wound healing (including an in-vitro fibroblast study in which TB-500 reportedly did not induce wound healing), and insufficient nonclinical and clinical safety data
US$ 23.45
US$ 25.41
US$ 28.11
US$ 25.50
US$ 22.81
US$ 24.63
